You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.

Clinical Advances in

Evidence-Based Approaches to Maximal Medical Management of Chronic Rhinosinusitis

Chronic rhinosinusitis (CRS) is a major cause of morbidity, lost productivity, and health expenditures in the United States. Though inflammatory in nature, the etiology of CRS is multifactorial and not attributable to any single factor. Surgery and intranasal steroids are the mainstays of therapy. Recent studies suggest that endotyping of CRS patients may soon allow for the use of biologic agents that target specific inflammatory pathways. This page provides education on evidence-based treatments for CRS, including devices that may improve delivery of therapies to the sinuses.

Supported by an independent educational grant from

OptiNose US, Inc.

CME Activities

Polling Question

Related Resources

Steering Committee

Raj Sindwani, MD

Chair

Raj Sindwani, MD

Vice Chairman and Section Head
Head and Neck Institute, Cleveland Clinic
Cleveland, Ohio

Rakesh Chandra, MD

Rakesh Chandra, MD

Professor, Chief-Rhinology & Skull Base Surgery
Vanderbilt University Medical Center
Nashville, Tennessee

Alexander Chiu, MD

Alexander Chiu, MD

Professor
Russell E. Bridwell, MD, Endowed Chair
University of Kansas Medical Center
Kansas City, Kansas

Daniel L. Hamilos, MD

Daniel L. Hamilos, MD

Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

James Palmer, MD

James Palmer, MD

Professor
Director, Division of Rhinology
Department of Otorhinolaryngology
Head and Neck Surgery
University of Pennsylvania
Philadelphia, Pennsylvania

Anju T. Peters, MD, MSCI

Anju T. Peters, MD, MSCI

Professor of Medicine
Director of Clinical Research
Northwestern University
Feinberg School of Medicine
Chicago, Illinois